WOLFGANG WINKELMAYER to Medicare
This is a "connection" page, showing publications WOLFGANG WINKELMAYER has written about Medicare.
Connection Strength
4.497
-
Trends in the Medical Complexity and Outcomes of Medicare-insured Patients Undergoing Kidney Transplant in the Years 1998-2014. Transplantation. 2019 11; 103(11):2413-2422.
Score: 0.504
-
The Role of Big Data in the Development and Evaluation of US Dialysis Care. Am J Kidney Dis. 2018 10; 72(4):560-568.
Score: 0.458
-
Timing of Dialysis Initiation-Do Health Care Setting or Provider Incentives Matter? Clin J Am Soc Nephrol. 2015 Aug 07; 10(8):1321-3.
Score: 0.375
-
Commentary on 'the DOPPS practice monitor for US dialysis care: potential impact of recent guidelines and regulatory changes on management of mineral and bone disorder among US hemodialysis patients': the calm before the 2016 storm? Am J Kidney Dis. 2014 May; 63(5):854-8.
Score: 0.344
-
Potential effects of the new Medicare Prospective Payment System on drug prescription in end-stage renal disease care. Blood Purif. 2011; 31(1-3):66-9.
Score: 0.274
-
Identification of individuals with CKD from Medicare claims data: a validation study. Am J Kidney Dis. 2005 Aug; 46(2):225-32.
Score: 0.188
-
Association Between Preoperative Hemodialysis Timing and Postoperative Mortality in Patients With End-stage Kidney Disease. JAMA. 2022 11 08; 328(18):1837-1848.
Score: 0.155
-
The Association of Pre-Kidney Transplant Dialysis Modality with de novo Posttransplant Heart Failure. Cardiorenal Med. 2021; 11(5-6):209-217.
Score: 0.143
-
Cause of kidney disease and cardiovascular events in a national cohort of US patients with end-stage renal disease on dialysis: a retrospective analysis. Eur Heart J. 2019 03 14; 40(11):887-898.
Score: 0.121
-
Evaluating the Evidence behind Policy Mandates in US Dialysis Care. J Am Soc Nephrol. 2018 12; 29(12):2777-2779.
Score: 0.118
-
Health Insurance in the First 3 Months of Hemodialysis and Early Vascular Access. Clin J Am Soc Nephrol. 2018 12 07; 13(12):1866-1875.
Score: 0.118
-
Sleep disordered breathing and cardiovascular risk in older patients initiating dialysis in the United States: a retrospective observational study using medicare data. BMC Nephrol. 2016 Feb 09; 17:16.
Score: 0.097
-
Trends in anemia care in older patients approaching end-stage renal disease in the United States (1995-2010). JAMA Intern Med. 2014 May; 174(5):699-707.
Score: 0.086
-
Temporal trends in the incidence, treatment and outcomes of hip fracture after first kidney transplantation in the United States. Am J Transplant. 2014 Apr; 14(4):943-951.
Score: 0.085
-
Comparison of Medicare claims versus physician adjudication for identifying stroke outcomes in the Women's Health Initiative. Stroke. 2014 Mar; 45(3):815-21.
Score: 0.085
-
Use of Medicare data to identify coronary heart disease outcomes in the Women's Health Initiative. Circ Cardiovasc Qual Outcomes. 2014 Jan; 7(1):157-62.
Score: 0.084
-
Trends in the incidence of atrial fibrillation in older patients initiating dialysis in the United States. Circulation. 2012 Nov 06; 126(19):2293-301.
Score: 0.077
-
Prevalence of atrial fibrillation and warfarin use in older patients receiving hemodialysis. J Nephrol. 2012 May-Jun; 25(3):341-53.
Score: 0.075
-
Validation of reported predialysis nephrology care of older patients initiating dialysis. J Am Soc Nephrol. 2012 Jun; 23(6):1078-85.
Score: 0.075
-
Trends in the incidence of intestinal perforation in US dialysis patients (1992-2005). J Nephrol. 2013 Mar-Apr; 26(2):281-8.
Score: 0.074
-
Effectiveness and safety of warfarin initiation in older hemodialysis patients with incident atrial fibrillation. Clin J Am Soc Nephrol. 2011 Nov; 6(11):2662-8.
Score: 0.072
-
Predialysis nephrology care of older patients approaching end-stage renal disease. Arch Intern Med. 2011 Aug 08; 171(15):1371-8.
Score: 0.071
-
Angiotensin receptor blockers and angiotensin-converting enzyme inhibitors: challenges in comparative effectiveness using Medicare data. Clin Pharmacol Ther. 2011 May; 89(5):674-82.
Score: 0.069
-
The 2011 ESRD prospective payment system: an uncontrolled experiment. Am J Kidney Dis. 2011 Apr; 57(4):542-6.
Score: 0.069
-
Comparative mortality risk of anemia management practices in incident hemodialysis patients. JAMA. 2010 Mar 03; 303(9):857-64.
Score: 0.064
-
Lessons from geographic variations in predialysis nephrology care. J Am Soc Nephrol. 2009 May; 20(5):930-2.
Score: 0.061
-
Clinical presentation of myocardial infarction contributes to lower use of coronary angiography in patients with chronic kidney disease. Kidney Int. 2007 May; 71(9):938-45.
Score: 0.052
-
Underuse of ACE inhibitors and angiotensin II receptor blockers in elderly patients with diabetes. Am J Kidney Dis. 2005 Dec; 46(6):1080-7.
Score: 0.048
-
A propensity analysis of late versus early nephrologist referral and mortality on dialysis. J Am Soc Nephrol. 2003 Feb; 14(2):486-92.
Score: 0.039
-
A Comparison of US Medicare Expenditures for Hemodialysis and Peritoneal Dialysis. J Am Soc Nephrol. 2022 Nov; 33(11):2059-2070.
Score: 0.038
-
Preventive health care measures before and after start of renal replacement therapy. J Gen Intern Med. 2002 Aug; 17(8):588-95.
Score: 0.038
-
Patient Health Outcomes following Dialysis Facility Closures in the United States. J Am Soc Nephrol. 2021 10; 32(10):2613-2621.
Score: 0.036
-
Long-Term Exposures to Air Pollution and the Risk of Atrial Fibrillation in the Women's Health Initiative Cohort. Environ Health Perspect. 2021 09; 129(9):97007.
Score: 0.036
-
Patient-Reported Experiences with Dialysis Care and Provider Visit Frequency. Clin J Am Soc Nephrol. 2021 07; 16(7):1052-1060.
Score: 0.035
-
Mortality, Kidney Failure, and Hospitalization Among Medicare Beneficiaries With CKD and Pulmonary Hypertension. Am J Kidney Dis. 2021 11; 78(5):700-708.e1.
Score: 0.035
-
Use of QT Prolonging Medications by Hemodialysis Patients and Individuals Without End-Stage Kidney Disease. J Am Heart Assoc. 2020 07 07; 9(13):e015969.
Score: 0.033
-
Safety-Net Care for Maintenance Dialysis in the United States. J Am Soc Nephrol. 2020 02; 31(2):424-433.
Score: 0.032
-
Implantable Ventricular Assist Device Use and Outcomes in People With End-Stage Renal Disease. J Am Heart Assoc. 2018 07 06; 7(14).
Score: 0.029
-
Effects of physician payment reform on provision of home dialysis. Am J Manag Care. 2016 06 01; 22(6):e215-23.
Score: 0.025
-
Epoetin Alfa and Outcomes in Dialysis amid Regulatory and Payment Reform. J Am Soc Nephrol. 2016 Oct; 27(10):3129-3138.
Score: 0.024
-
Provider visit frequency and vascular access interventions in hemodialysis. Clin J Am Soc Nephrol. 2015 Feb 06; 10(2):269-77.
Score: 0.023
-
Physician visits and 30-day hospital readmissions in patients receiving hemodialysis. J Am Soc Nephrol. 2014 Sep; 25(9):2079-87.
Score: 0.022
-
Delayed nephrologist referral and inadequate vascular access in patients with advanced chronic kidney failure. J Clin Epidemiol. 2002 Jul; 55(7):711-6.
Score: 0.009